The objective of the program is to acquire a specialized knowledge in corporate finance and corporate law in late stage negotiation agreements between pharma and biotech in portfolio management. The main skills and topics are related with international negotiation processes in licensing agreements or merge and acquisitions, corporate finance and corporate law for the deal head establishment, upfront and milestones.
Pre-selection process: Open
Inscriptions : from October 2019 to January 2020
The students of our master programs will have the opportunity to work in teams of some of the most important global pharmaceutical companies as well as new biotechnology companies, developing innovative products inside the biomedical sector. Their demanded profiles allow the students to work in different roles and departments in biotech companies, consultancies, pharmaceutical companies, technology transfer offices from hospitals and research centers.
Credits - 30 / European ECTS credits
Postgraduate Programs – 2019-2020 Edition
Full Time - Monday to Thursday from 18:00h. to 21:00h.
Language - English